D-0002-2020 Class III Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0002-2020 was initiated by Pfizer Inc. on Sep 12, 2019 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020. The recall status is terminated (terminated Apr 10, 2023). Affected quantity: 7,686 100-count bottles.

Recall details

Product Type
Drugs
Report Date
Oct 2, 2019
Initiation Date
Sep 12, 2019
Termination Date
Apr 10, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,686 100-count bottles

Product description

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.

Distribution pattern

Nationwide in the USA

Code information

Lot #3267079, Exp 09/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0002-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0002-2020. Report a data issue: hello@regdatalab.com.